Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 4,564 TARS shares, $387.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 4,564 | $387.9K |
| Mar 24, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 2,989 | $199.5K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 3,125 | $216.9K |
| Mar 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 26,287 | n/a |
| Mar 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 27,310 | n/a |
| Mar 5, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 8,366 | $641.4K |
| Dec 18, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Gift | 950 | n/a |
| Mar 21, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 2,605 | $120.6K |
| Mar 19, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 21,264 | n/a |
| Mar 7, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 30,628 | n/a |